Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2850427 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Bone Morphogenetic Protein Receptor, Type II (serine/threonine Kinase) (BMPR2) (AA 28-59), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 28-59, N-Term
- Antibody clone number
- RB01778
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots.
- Handling
- Avoid freeze-thaw cycles.
Submitted references BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells.
Correlating the effects of bone morphogenic protein to secreted soluble factors from fibroblasts and mesenchymal stem cells in regulating regenerative processes in vitro.
Roles of miR-1-1 and miR-181c in ventricular septal defects.
Binding of carbon nanotube to BMP receptor 2 enhances cell differentiation and inhibits apoptosis via regulating bHLH transcription factors.
Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Dysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension.
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro.
Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.
Srikanth M, Kim J, Das S, Kessler JA
Molecular cancer research : MCR 2014 Feb;12(2):283-94
Molecular cancer research : MCR 2014 Feb;12(2):283-94
Correlating the effects of bone morphogenic protein to secreted soluble factors from fibroblasts and mesenchymal stem cells in regulating regenerative processes in vitro.
Lynch KM, Ahsan T
Tissue engineering. Part A 2014 Dec;20(23-24):3122-9
Tissue engineering. Part A 2014 Dec;20(23-24):3122-9
Roles of miR-1-1 and miR-181c in ventricular septal defects.
Li J, Cao Y, Ma XJ, Wang HJ, Zhang J, Luo X, Chen W, Wu Y, Meng Y, Zhang J, Yuan Y, Ma D, Huang GY
International journal of cardiology 2013 Sep 30;168(2):1441-6
International journal of cardiology 2013 Sep 30;168(2):1441-6
Binding of carbon nanotube to BMP receptor 2 enhances cell differentiation and inhibits apoptosis via regulating bHLH transcription factors.
Zhang Y, Mu Q, Zhou H, Vrijens K, Roussel MF, Jiang G, Yan B
Cell death & disease 2012 May 10;3:e308
Cell death & disease 2012 May 10;3:e308
Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Jara A, Chacón C, Burgos ME, Droguett A, Valdivieso A, Ortiz M, Troncoso P, Mezzano S
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009 Apr;24(4):1121-9
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009 Apr;24(4):1121-9
Dysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension.
Sehgal PB, Mukhopadhyay S, Xu F, Patel K, Shah M
American journal of physiology. Lung cellular and molecular physiology 2007 Jun;292(6):L1526-42
American journal of physiology. Lung cellular and molecular physiology 2007 Jun;292(6):L1526-42
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro.
Ramos M, Lamé MW, Segall HJ, Wilson DW
Vascular pharmacology 2006 Jan;44(1):50-9
Vascular pharmacology 2006 Jan;44(1):50-9
Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
Pouliot F, Blais A, Labrie C
Cancer research 2003 Jan 15;63(2):277-81
Cancer research 2003 Jan 15;63(2):277-81
Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.
Nishihara A, Watabe T, Imamura T, Miyazono K
Molecular biology of the cell 2002 Sep;13(9):3055-63
Molecular biology of the cell 2002 Sep;13(9):3055-63
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC